Biotrends India Profile
Key Indicators
- Authorised Capital ₹ 1.75 Cr
- Paid Up Capital ₹ 9.85 M
- Company Age 5 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.13 M
- Revenue Growth 16.27%
- Profit Growth 7.17%
- Ebitda 631.60%
- Net Worth 35.92%
- Total Assets 9.00%
About Biotrends India
Biotrends India Private Limited (BIPL) is a registered startup operating as a Private Limited Indian Non-Government Company incorporated in India on 26 December 2019 (Five years and two months 0 days old ). Its registered office is in Delhi, India.
The Company is engaged in the Agriculture Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 1.75 Cr and a paid-up capital of Rs 9.85 M.
The company currently has active open charges totaling ₹6.13 M.
Indranil Das, Archana Das, and Agneev Das serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74999DL2019PTC359336
- Company No.
359336
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
26 Dec 2019
- Date of AGM
25 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Who are the key members and board of directors at Biotrends India?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Indranil Das  | Managing Director | 26-Dec-2019 | Current |
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Archana Das | Director | 26-Dec-2019 | Current |
| Agneev Das | Director | 24-Aug-2022 | Current |
Financial Performance of Biotrends India.
Biotrends India Private Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 16.27% increase. The company also saw a slight improvement in profitability, with a 7.17% increase in profit. The company's net worth Soared by an impressive increase of 35.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Biotrends India?
In 2023, Biotrends India had a promoter holding of 82.61% and a public holding of 17.39%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.61 Cr
₹0
Charges Breakdown by Lending Institutions
- Canara Bank : 0.53 Cr
- Hdfc Bank Limited : 0.08 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 13 Jun 2022 | Canara Bank | ₹5.29 M | Open |
| 21 Oct 2020 | Hdfc Bank Limited | ₹0.84 M | Open |
How Many Employees Work at Biotrends India?
Unlock and access historical data on people associated with Biotrends India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Biotrends India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Biotrends India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
